TRIM (1-(2-Trifluoromethylphenyl)imidazole) is a selective neuronal nitric oxide synthase (nNOS) inhibitor. It is a valuable research tool for investigating the role of nNOS in neurological functions and disorders, applicable in both in vitro and in vivo experimental models.